Military Veterans Join Virtue Recovery to Expand Community Outreach With Hope and Support
Virtue Recovery has expanded its Business Development Team with the addition of two American Veterans, Adam Khosroabadi and Chauncy Nash....
Addiction
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Alliance Recovery Expands in Orange County, California, Improving Access to Affordable Addiction Treatment
Expansion at Alliance Recovery in Orange County, CA increases treatment capacity by 16 and paves the way for a future...
eClinicalWorks and healow Genie to Enhance Patient Experiences at Evolve Psychiatry
The 27-provider practice to revolutionize patient communication and operational efficiency with the AI-powered contact center solutionWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest...
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
Hyperbaric oxygen therapy pioneer and Aviv Clinics medical advisor honored for research and service to veterans and patients with stroke,...
InventHelp Inventor Develops Sobriety Smart Watch (TLS-892)
PITTSBURGH, Aug. 25, 2025 /PRNewswire/ -- "I wanted to create a smart watch system that would provide supportive reminders to...
Nest Health Raises Series A to Expand Nation’s Leading In-Home Family Care Model for Medicaid Amid Historic Policy Shifts
NEW ORLEANS, Aug. 25, 2025 /PRNewswire/ -- Nest Health, the nation's leading in-home, whole-family care provider for families on Medicaid,...
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY /...
Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI
The GenAI-powered platform automates benefit verification, prior authorization, and payer follow-up to reduce treatment delays and manual burdenSAN FRANCISCO--(BUSINESS WIRE)--Develop...
Tribe Intensive NJ Launches Evening IOP for Working Professionals
MARLTON, N.J., Aug. 20, 2025 /PRNewswire/ -- Tribe Intensive NJ, a premier dual-diagnosis addiction treatment provider offering both partial hospitalization...
Adial Pharmaceuticals Encouraged By U.S. Senate Support for Expanded Clinical Trial Endpoints Beyond Abstinence in Alcohol and Substance Use Disorder Treatments
U.S. Senate Appropriations Report Further Validates Adial’s Therapeutic Approach and Promotes a More Contemporary Patient Focused Regulatory EnvironmentGLEN ALLEN, Va.,...
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help...
Dismas Charities Expands Use of Atlas Digital Behavioral Health Platform to 40 Sites Nationwide
After a successful pilot, Dismas Charities partners with The Change Companies to bring individualized, digital-first programming to justice-involved individuals. CARSON...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
Ensysce Biosciences’ Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
Pres. Trump’s Chance to Fix DEA’s Marijuana Policy Failures: Rescheduling?
DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years...
Fentanyl: #1 Killer of Americans 18-45: An Estimated 1 Million Parents Have Lost Children to the Ongoing Epidemic
We're Out of Time Podcast Host & Addiction Recovery Expert Richard Taite Endorses Bereaved Parents' Nationwide, In-School Fentanyl Prevention Effort...
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment...
Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions
- Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to...